Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium falciparum | plasmepsin IV | 0.0304 | 0.1364 | 0.139 |
Plasmodium vivax | aspartyl protease, putative | 0.1078 | 0.61 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium falciparum | plasmepsin VI | 0.0304 | 0.1364 | 0.139 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium falciparum | plasmepsin VIII, putative | 0.0192 | 0.0682 | 0.0151 |
Plasmodium falciparum | plasmepsin VII | 0.0192 | 0.0682 | 0.0151 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0304 | 0.1364 | 0.139 |
Plasmodium falciparum | plasmepsin V | 0.0192 | 0.0682 | 0.0151 |
Trypanosoma brucei | RNA helicase, putative | 0.0081 | 0 | 0.5 |
Onchocerca volvulus | 0.0192 | 0.0682 | 0.5 | |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.0192 | 0.0682 | 0.5 |
Plasmodium falciparum | plasmepsin I | 0.0304 | 0.1364 | 0.139 |
Loa Loa (eye worm) | hypothetical protein | 0.0304 | 0.1364 | 1 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0192 | 0.0682 | 0.0151 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0304 | 0.1364 | 0.139 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Brugia malayi | hypothetical protein | 0.0192 | 0.0682 | 0.5 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0304 | 0.1364 | 1 |
Plasmodium vivax | aspartyl protease, putative | 0.0192 | 0.0682 | 0.0151 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0304 | 0.1364 | 0.139 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium vivax | plasmepsin V, putative | 0.0192 | 0.0682 | 0.0151 |
Plasmodium vivax | aspartyl protease, putative | 0.1078 | 0.61 | 1 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.0192 | 0.0682 | 0.5 |
Schistosoma mansoni | family A2 unassigned peptidase (A02 family) | 0.0231 | 0.0923 | 0.0923 |
Toxoplasma gondii | eukaryotic aspartyl protease superfamily protein | 0.0192 | 0.0682 | 0.0151 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium falciparum | plasmepsin III | 0.0192 | 0.0682 | 0.0151 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0304 | 0.1364 | 0.5 |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.0192 | 0.0682 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium falciparum | plasmepsin X | 0.1078 | 0.61 | 1 |
Brugia malayi | Pepsin A precursor | 0.0192 | 0.0682 | 0.5 |
Brugia malayi | hypothetical protein | 0.0192 | 0.0682 | 0.5 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.1716 | 1 | 1 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0192 | 0.0682 | 0.0682 |
Plasmodium falciparum | plasmepsin IX | 0.1078 | 0.61 | 1 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.1078 | 0.61 | 1 |
Schistosoma mansoni | intracisternal A-particle retropepsin (A02 family) | 0.1273 | 0.7292 | 0.7292 |
Plasmodium falciparum | plasmepsin II | 0.0304 | 0.1364 | 0.139 |
Onchocerca volvulus | 0.0192 | 0.0682 | 0.5 | |
Toxoplasma gondii | aspartyl protease | 0.0192 | 0.0682 | 0.0151 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0304 | 0.1364 | 0.5 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0304 | 0.1364 | 0.5 |
Plasmodium vivax | plasmepsin IV, putative | 0.0304 | 0.1364 | 0.139 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0304 | 0.1364 | 0.1364 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = -9.12 | Inhibition of CpG-oligodeoxynucleotides-induced immunostimulation in mouse WEHI 231 cells | ChEMBL. | 17049254 |
Log 1/EC50 (functional) | = 9.12 | Ability to reverse action of CpG-ODN on WEHI 231 murine B-cell lymphoma cells | ChEMBL. | 12646034 |
Log EC50 (functional) | = 9.12 | Inhibition of CpG-oligodeoxynucleotides-induced immunostimulation in mouse WEHI 231 cells | ChEMBL. | 17049254 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 17049254 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.